Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).


TSX:MSCL - Post by User

Comment by allain250on Jul 17, 2018 2:47pm
73 Views
Post# 28328456

RE:.22 open tomorrow

RE:.22 open tomorrow

Antisense Oligonucleotides Market Register a Hugh Growth In Pharmaceutical Industry by 2026

Antisense Oligonucleotides Market Register a Hugh Growth In Pharmaceutical Industry by 2026
 

Antisense Oligonucleotides Market Report provides an analytical assessment of the prime challenges faced by this Market currently and in the coming years, which helps Market participants in understanding the problems they may face while operating in this Market over a longer period of time.

Various Antisense Oligonucleotides Market industry leading players are studied with respect to their company profile, product portfolio, capacity, price, cost and revenue.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1879

Major Players in the Market: Pharmaceuticals Inc., Sarepta Therapeutics Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Antisense Therapeutics Ltd., Isarna Therapeutics GmbH, Arrowhead Pharmaceuticals Inc., Atlantic pharmaceuticals Inc., Enzon Pharmaceuticals Inc., Bio-Path Holdings Inc., Glaxo smith Kline Plc., Gene Signal International SA., Geron Corporation, Gradlis Inc., ICO Therapeutics Inc., Aptose Biosciences Inc., Marina Biotech Inc., miRagen Therapeutics Inc., Synlogic Inc., OncoGenex Pharmaceuticals Inc., Pharmaxis Ltd., Rexahn Pharmaceuticals Inc., Regulus Therapeutics Inc., and Rxi Pharmaceuticals Inc.

The Antisense Oligonucleotides Market to grow at a substantial Compound Annual Growth Rate during the forecast period 2018-2026. RF Inductors Market Report Segmented by Regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa, Rest of World (ROW). Market segmentation by Product Type and Applications are mentioned.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in B rain Health Devices Market at –

Table of Content (ToC) at a glance:

https://www.coherentmarketinsights.com/ongoing-insight/toc/1879

Report includes chapters which deeply display the following deliverable about industry:

Antisense Oligonucleotides Market Research Objective and Assumption

Antisense Oligonucleotides Market Purview – Report Description, Executive Summary, and Coherent Opportunity Map (COM)

Antisense Oligonucleotides Market Dynamics, Regulations, and Trends Analysis – Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis

Global IAntisense Oligonucleotides Market , By Regions

Antisense Oligonucleotides Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.

Antisense Oligonucleotides Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors.

Antisense Oligonucleotides Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials.

Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers

Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List.

Market Effect Factors Analysis  including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change.

Antisense Oligonucleotides Market Forecast  including Production, Consumption, Import and Export Forecast by Type, Applications and Region.

Research Findings and Conclusion


<< Previous
Bullboard Posts
Next >>